ArticleJournal of managed care & specialty pharmacy2024

Real-world economic burden associated with disease progression from metastatic castration-sensitive to castration-resistant prostate cancer on treatment in the United States.

Deborah R Kaye et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.